Role of herg1 K+ channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation

Hematology

Volumn 16, Issue 3, 2011, Pages 177-184

  Zheng, Fang ^a   Li, Huiyu ^a   Du, Wen ^a   Huang, Shiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Herg1 K+ channels; Leukemia; Proliferation; SDF 1

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL HERG 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMOGENESIS; MICROENVIRONMENT; MONONUCLEAR CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; BETA CATENIN; CELL CYCLE; CELL PROLIFERATION; CHEMOKINE CXCL12; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHER-A-GO-GO POTASSIUM CHANNELS; FLOW CYTOMETRY; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79958711669     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12940641878000     Document Type: Article

References (31)

1. Konopleva M, Tabe Y, Zeng Z, Andreeff M. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches. Drug Resist Updat 2009;12:103-113.
2. Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 2008;322:1861-1865.
3. Fiegl M, Samudio I, Clise-Dwyer K, Burks JK, Mnjoyan Z, Andreeff M. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 2009;113:1504-1512.
4. Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106:1154-1163.
5. Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006;368:1894-1907.
6. Kryczek I, Wei S, Keller E, Liu R, Zou W. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 2007;292:C987-C995.
7. Zeng Z, Shi YX, Samudio IJ, Wang RY, Ling X, Frolova O, et al. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 2009;113:6215-6224.
8. Mowafi F, Cagigi A, Matskova L, Björk O, Chiodi F, Nilsson A. Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation. Pediatr Blood Cancer 2008;50:812-817.
9. Spoo AC, Lubbert M, Wierda WG, Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 2007: 10; 9786-9791.
10. + channels and SDF-1 in acute leukemic cell migration. Exp Cell Res 2009;315:2256-2264.
11. + channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. J Biol Chem 2004;279:13289-13292.
12. Pillozzi S, Brizzi MF, Balzi M, Crociani O., Cherubini A., Guasti L, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 2002;16:1791-1798.
13. + channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood 2007;110:1238-1250.
14. Chen CC, Gau JP, You JY, Lee KD, Yu YB, Lu CH, et al. Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia. Am J Hematol 2009;84:87-92.
15. Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010;327:1650-1653.
16. Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis 2008;4:68-75.
17. Tavor S, Petit I, Porozov S, Avigdor A, Dar A, Leider-Trejo L, et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/ SCID mice. Cancer Res 2004;64:2817-2824.
18. + channels in neoplastic hematopoietic cells. J Biol Chem 2002;277:18528-18534.
19. Tavor S, Petit I, Porozov S, Goichberg P, Avigdor A, Sagiv S, et al. Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice. Blood 2005;106:2120-2127.
20. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 2002;62:5930-5938.
21. Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M, et al. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 2003;278:2947-2955.
22. Wang Z. Roles of Kz Channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 2004;448:274-286.
23. Simon M, Grandage VL, Linch DC, Khwaja A. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene 2005;24:2410-2420.
24. Ysebaert L, Chicanne G, Demur C, de Toni F, Prade-Houdellier N, Ruidavets JB, et al. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis. Leukemia 2006;20:1211-1216.
25. Wilusz M, Majka M. Role of the Wnt/beta-catenin network in regulating hematopoiesis. Arch Immunol Ther Exp (Warsz) 2008;56:257-266.
26. Macheda ML, Stacker SA. Importance of Wnt signaling in the tumor stroma microenvironment. Curr Cancer Drug Targets 2008;8:454-465.
27. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
28. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
29. Li YJ, Wei ZM, Meng YX, Ji XR. Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 2005;11:2117-2123.
30. Luo Y, Cai J, Xue H, Mattson MP, Rao MS. SDF1alpha/ CXCR4 signaling stimulates beta-catenin transcriptional activity in rat neural progenitors. Neurosci Lett 2006;398:291-295.
31. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003: 94: 225-229.